Anika
Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President
and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be
presenting at the 10th Annual Canaccord Genuity
Musculoskeletal Conference on Tuesday, March 24, 2015 at 12:30 p.m. ET/
9:30 a.m. PT. The conference is being held at the MGM Grand Hotel in Las
Vegas, Nevada.
A live audio webcast of the presentation may be accessed via the “Investor
Relations” section of Anika’s website at www.anikatherapeutics.com.
An audio archive of the presentation also will be available on the
website.
About Anika Therapeutics, Inc.
Headquartered in Bedford, Mass., Anika
Therapeutics, Inc. develops, manufactures and commercializes
therapeutic products for tissue protection, healing and repair. These
products are based on hyaluronic
acid (HA), a naturally occurring, biocompatible polymer found
throughout the body. Anika's products range from orthopedic/joint health
solutions led by Orthovisc
and Monovisc,
treatments for osteoarthritis of the knee, to surgical aids in the anti-adhesion
and ophthalmic
fields. The Company also offers aesthetic
dermal fillers for the correction of facial wrinkles. Anika's
Italian subsidiary, Anika Therapeutics S.r.l., provides complementary HA
products in orthopedic/joint health and anti-adhesion, as well as
therapeutics in areas such as advanced wound treatment and ear, nose and
throat care. Its regenerative technology advances Anika's vision to
offer therapeutic products and medical solutions that go beyond pain
relief to protect and restore damaged tissue.
Copyright Business Wire 2015